share_log

Baird Starts Dianthus Therapeutics With Outperform Rating, $58 Price Target

Baird Starts Dianthus Therapeutics With Outperform Rating, $58 Price Target

貝爾德以$58的目標價,啓動對多花嗪治療的跟蹤,評級爲增持。
MT Newswires ·  07/26 04:20  · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論